Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Commodore Capital LP (CIK 1831942) reported $1.73B across 33 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: RLAY ($169.2M, 9.79%), ALKS ($148.5M, 8.59%), ELVN ($128.4M, 7.43%), COGT ($111.2M, 6.43%), SYRE ($96.5M, 5.58%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | RLAY | RELAY THERAPEUTICS INC | $169.2M | 9.79% | 17.0M | Hold |
| 2 | ALKS | ALKERMES PLC | $148.5M | 8.59% | 4.2M | Added |
| 3 | ELVN | ENLIVEN THERAPEUTICS INC | $128.4M | 7.43% | 3.3M | Trimmed |
| 4 | COGT | COGENT BIOSCIENCES INC | $111.2M | 6.43% | 2.9M | Added |
| 5 | SYRE | SPYRE THERAPEUTICS INC | $96.5M | 5.58% | 1.9M | Trimmed |
| 6 | TYRA | TYRA BIOSCIENCES INC | $94.8M | 5.48% | 2.5M | Trimmed |
| 7 | CLDX | CELLDEX THERAPEUTICS INC NEW | $85.5M | 4.95% | 2.7M | Added |
| 8 | NUVL | NUVALENT INC | $85.4M | 4.94% | 833,600 | Added |
| 9 | AMLX | AMYLYX PHARMACEUTICALS INC | $78.5M | 4.54% | 5.7M | Hold |
| 10 | KYMR | KYMERA THERAPEUTICS INC | $62.5M | 3.61% | 750,000 | Hold |
| 11 | ANRO | ALTO NEUROSCIENCE INC | $61.2M | 3.54% | 2.7M | Added |
| 12 | PHVS | PHARVARIS N V | $54.2M | 3.14% | 1.9M | Added |
| 13 | ERAS | ERASCA INC | $51.4M | 2.97% | 3.2M | New |
| 14 | GLTO | DAMORA THERAPEUTICS INC | $50.2M | 2.91% | 1.9M | New |
| 15 | XENE | XENON PHARMACEUTICALS INC | $48.0M | 2.78% | 825,000 | Trimmed |
| 16 | DEFINIUM THERAPEUTICS INC | $37.8M | 2.19% | 2.0M | New | |
| 17 | LB PHARMACEUTICALS INC | $37.0M | 2.14% | 1.5M | Hold | |
| 18 | EYPT | EYEPOINT INC | $36.4M | 2.11% | 2.8M | New |
| 19 | NRIX | NURIX THERAPEUTICS INC | $35.3M | 2.04% | 2.3M | Hold |
| 20 | CRVS | CORVUS PHARMACEUTICALS INC | $33.0M | 1.91% | 2.3M | New |
| 21 | ASMB | ASSEMBLY BIOSCIENCES INC | $27.8M | 1.61% | 1.0M | Hold |
| 22 | CATX | PERSPECTIVE THERAPEUTICS INC | $26.4M | 1.53% | 6.3M | New |
| 23 | SLNO | SOLENO THERAPEUTICS INC | $21.8M | 1.26% | 652,432 | Trimmed |
| 24 | OCUL | OCULAR THERAPEUTIX INC | $21.8M | 1.26% | 2.6M | New |
| 25 | IPSC | CENTURY THERAPEUTICS INC | $19.7M | 1.14% | 8.7M | New |
Source: SEC Form 13F filings · as of 2026-03-31